GA SB433 | 2019-2020 | Regular Session
Status
Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on February 24 2020 - 25% progression, died in committee
Action: 2020-02-25 - Senate Read and Referred
Pending: Senate Insurance and Labor Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 24 2020 - 25% progression, died in committee
Action: 2020-02-25 - Senate Read and Referred
Pending: Senate Insurance and Labor Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to require disclosure of diabetes prescription drug pricing; to provide for a short title; to provide for legislative findings; to provide for definitions; to provide for a listing of diabetes prescription drugs; to provide for drug manufacturer and pharmacy benefits manager report forms and insurer pricing reports; to provide for certain other reports; to provide for penalties; to amend Chapter 1 of Title 10 of the Official Code of Georgia Annotated, relating to selling and other trade practices, so as to provide for penalties regarding unfair or deceptive practices in consumer transactions; to provide for related matters; to provide for an effective date and applicability; to repeal conflicting laws; and for other purposes.
Title
'Diabetes Drug Pricing Transparency Act of 2020'; disclosure of diabetes prescription drug pricing; require
Sponsors
Sen. Burt Jones [R] | Sen. Lee Anderson [R] | Sen. Dean Burke [R] | Sen. P.K. Martin [R] |
Sen. Matt Brass [R] |
History
Date | Chamber | Action |
---|---|---|
2020-02-25 | Senate | Senate Read and Referred |
2020-02-24 | Senate | Senate Hopper |
Georgia State Sources
Type | Source |
---|---|
Summary | https://www.legis.ga.gov/legislation/57701 |
Text | https://www.legis.ga.gov/api/legislation/document/20192020/190785 |